NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-015-2011-0-AU-03 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer AU National Stage 2012271403 Issued
NICHD E-010-2010-0-US-04 Method For Detecting Hematoma, Portable Detection and Discrimination Device and Related Systems and Apparatuses US National Stage 13/516,480 9861287 Issued PDF
NCI E-015-2011-0-EP-05 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer EP National Stage 12800764.8 Issued
NCI E-015-2011-0-GB-11 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer GB EP 12800764.8 Issued
NCI E-015-2011-0-DE-09 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer DE EP 12800764.8 Issued
NCI E-015-2011-0-FR-10 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer FR EP 12800764.8 Issued
NCI E-015-2011-0-PCT-02 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer. PCT PCT PCT/US12/42753 Expired
NCI E-015-2011-0-EP-08 Nuclear Receptor Modulators And Their Use For The Treatment And Prevention Of Cancer EP DIV 17211083.5 Issued
NICHD E-348-2013-0-HU-01 BIOMARKER TEST FOR PREDICTION OR EARLY DETECTION OF PREECLAMPSIA AND/OR HELLP SYNDROME HU ORD P1200368 Pending
NCI E-077-2017-0-US-01 CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE US 61/660,172 Abandoned
CC E-227-2012-0-US-01 System, Method And Device For Prostate Diagnosis And Intervention US 61/659,730 Abandoned
NCI E-024-2011-0-PCT-02 TEM8 Antibodies, Conjugates Thereof, And Their Use. PCT PCT PCT/US2012/042315 Expired
NCI E-024-2011-0-EP-05 TEM8 Antibodies, Conjugates Thereof, And Their Use EP National Stage 12799947.2 Abandoned
NCI E-024-2011-0-JP-06 TEM8 Antibodies, Conjugates Thereof, And Their Use JP National Stage 2014-515968 Abandoned
NCI E-024-2011-1-PCT-02 COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING TEM8 PCT PCT PCT/IB12/052990 Abandoned
NCI E-024-2011-0-AU-03 TEM8 Antibodies, Conjugates Thereof, And Their Use AU National Stage 2012271645 Abandoned
NCI E-024-2011-0-CA-04 TEM8 Antibodies, Conjugates Thereof, And Their Use CA National Stage 2837892 Abandoned
NCI E-321-2006-0-US-04 Treatment Of Skin Conditions By Dickkopf1 (DKK1) US DIV 13/492,990 8476236 Abandoned PDF
NCATS E-268-2009-0-US-03 DELIVERY OF TRANSTHYRETIN ACROSS THE BLOOD-BRAIN BARRIER AS A TREATMENT FOR ALZHEIMER'S DISEASE. US National Stage 13/515,050 Abandoned
NINDS E-251-2005-0-US-11 Enhance Recovery Of Voluntary Swallowing Using Patient Control Of Vibro-tactile Stimulation To The Neck In Persons With Dysphagia Resulting From A Neurological Diseases Or Disorders US DIV 13/492,044 Abandoned
NCI E-174-2011-0-CA-05 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes CA National Stage 2838013 Issued
NCI E-174-2011-0-CN-06 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes CN National Stage 201280039071.1 Issued
NCI E-174-2011-0-EP-17 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes EP DIV 17163568.3 Issued
NCI E-174-2011-0-DE-25 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes DE EP 17163568.3 Issued
NCI E-174-2011-0-FR-26 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes FR EP 17163568.3 Issued
NCI E-174-2011-0-GB-27 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes GB EP 17163568.3 Issued
NCI E-174-2011-0-EP-07 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes EP National Stage 12727074.2 Issued
NCI E-174-2011-0-KR-10 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes KR National Stage 10-2013-7032402 Abandoned
NCI E-174-2011-0-JP-09 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes JP National Stage 2014-514616 Issued
NCI E-174-2011-0-AU-03 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes AU National Stage 2012268013 Issued
NCI E-174-2011-0-PCT-02 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes PCT PCT PCT/US2012/041234 Expired
NCI E-174-2011-0-BR-04 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes BR National Stage BR112013031262-9 Abandoned
NCI E-174-2011-0-MX-11 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes MX National Stage MX/a/2013/014388 Issued
NCATS E-203-2012-0-US-01 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1 US 61/656,806 Abandoned
NCI E-081-2015-0-US-01 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES US 61/656,717 Abandoned
NIA E-158-2012-2-US-01 Use of Erythropoietin And Derivatives For Treating Hypertension. US 61/656,698 Abandoned
NCI E-269-2011-0-US-01 Kits For Detecting And Monitoring Endocrine Disrupting Chemicals (EDCs) US 61/656,473 Abandoned
NIDDK E-248-2004-0-JP-13 PURINE DERIVATIVES AS A3 AND A1 ADENOSINE RECEPTOR AGONISTS JP DIV 128779/2012 Abandoned
NIAID E-109-2007-1-US-04 Detection Of Infectious Prion Protein By Seeded Conversion Of Recombinant Prion Protein US CON 13/489,321 Abandoned
NHLBI E-291-2009-0-US-03 Hydrazone And Diacyl Hydrazine Compounds And Methods Of Use US National Stage 13/513,819 8518968 Issued PDF
NCI E-025-2010-0-US-06 Diazeniumdiolated Compounds, Pharmaceutical Compositions, and Method of Treating Cancer US National Stage 13/509,431 9205091 Issued PDF
NCI E-136-2012-0-US-01 High-affinity Monoclonal Antibodies To Glypican-3 And Use Thereof US 61/654,232 Abandoned
NHLBI E-292-2009-0-US-03 Signal-to-noise Enhancement In Imaging Applications Using A Time-Series of Images US National Stage 13/513,150 8942454 Issued PDF
NCI E-133-2009-0-US-03 Nitroxide Therapy For The Treatment Of Von Hippel-Lindau Disease (VHL) And Renal Clear Cell Carcinoma (RCC) US National Stage 13/512,665 8853277 Issued PDF
NCI E-059-2007-2-US-06 GP100-Specific T Cell Receptors And Related Materials and Methods of Use US DIV 13/483,286 8613932 Abandoned PDF
NCI E-207-2008-0-US-03 Dual Specific Immunotoxin for Brain Tumor Therapy US CON 13/482,406 Abandoned
NIDDK E-194-2012-0-US-01 Eukaryotic Transposase Mutants And Transposon End Compositions For Modifying Nucleic Acids And Methods For Production And Use In The Generation Of Sequencing Libraries US 61/652,560 Abandoned
NIMH E-274-2015-0-US-03 Compositions and Methods for Treating Bladder Cancer US National Stage 13/502,132 9321820 Issued PDF
NIAID E-252-2012-0-PCT-02 Kunitz Inhibitor Of Proteases PCT PCT PCT/US2012/039585 Expired
NCI E-293-2010-0-PCT-02 Lipopeptide Inhibitors Of RAS Oncoproteins PCT PCT PCT/US12/39623 Expired